Research & Development



  葉紅玉摸了它腦袋一下,笑道︰“小寶也認出來了是不是?”   換了之前,他還會覺得陸老大身上有些匪氣,但是現在瞧在眼里全變成了力大無窮又平易近人的樣子,他坐在那等的時候,泡了一壺茶,以前跟在外公黎老身邊的時候學過這些,還算拿的出手。av在线观看   而且現在用的伎倆也不怎麼高明,江心遠自己在乎權力金錢,便拿這些來利誘,從物質和感情一起許下空頭支票。超碰在线视频人人av   黎舟道︰“你怎麼會怕他,你可比他凶多了。”   這跟黎舟想的差不多,跟他敲定了時間,反倒是陸老大夫妻坐在那有些不敢相信。大香蕉电影   刁明山有點驚訝,但是他畢竟不是黎家人,只能謹慎道︰“別院那邊怎麼說?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo